COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,051 Articles (22,627 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 577: Articles 5761-5770  | Next

Meeting the 2030 End TB goals in the wake of COVID-19: a modelling study of countries in the USAID TB portfolio
Arinaminpathy, N., Mukadi, Y. D., Bloom, A., Vincent, C., Ahmedov, S.
10.1101/2022.10.20.22281311 — Posted: 2022-10-21
Virtual care use prior to emergency department admissions during a stable COVID-19 period in Ontario, Canada
Stamenova, V., Chu, C., Borgundvaag, E., Fleury, C., Brual, J., Bhattacharyya, O., Tadrous, M.
10.1101/2022.10.20.22281298 — Posted: 2022-10-21
Changes in Treatment and Severity of Multisystem Inflammatory Syndrome in Children: An EHR-based cohort study from the RECOVER program
Schuchard, J., Thacker, D., Webb, R., Bailey, C., Bennett, T. D., Cogen, J. D., Jhaveri, R., Jone, P.-N., Lee, G. M., Maltenfort, M., Mejias, A., Rogerson, C. M., Schulert, G. S., Mendonca, E. A., RECOVER consortium
10.1101/2022.10.19.22281256 — Posted: 2022-10-21
Fatigue presentation, severity, and related outcomes 12 weeks post-COVID-19 hospitalization
Magel, T., Meagher, E., Boulter, T., Albert, A., Tsai, M., Munoz, C., Carlsten, C., Johnston, J., Wong, A., Shah, A., Ryerson, C., McKay, R. J., Nacul, L.
10.1101/2022.10.18.22280199 — Posted: 2022-10-20
Estimating LFT and qPCR test-sensitivity over time since infection from a human challenge study
Davis, E. L., Hollingsworth, D.
10.1101/2022.10.18.22280274 — Posted: 2022-10-20
Impact of a vaccine passport on first-dose COVID-19 vaccine coverage by age and area-level social determinants in the Canadian provinces of Quebec and Ontario: an interrupted time series analysis
Flores Anato, J. L., Ma, H., Hamilton, M. A., Xia, Y., Harper, S., Buckeridge, D., Brisson, M., Hillmer, M. P., Malikov, K. A., Kerem, A., Beall, R., Baral, S., Dube, E., Mishra, S., Maheu-Giroux, M.
10.1101/2022.10.18.22281192 — Posted: 2022-10-20
Cumulative COVID-19 incidence indicators should account for the population-at-risk dynamics
Masjuan, P., Trias-Llimos, S., Rojas, C., Prakash, A., Gullon, P., Tobias, A., Lopez-Gay, A.
10.1101/2022.10.18.22281225 — Posted: 2022-10-20
ALCOHOLIC LIVER BIOMARKERS: DETERMINANTS FOR ADMISSION TO REHABILITATION CENTRES DURING THE COVID 19 PERIOD IN KENYA
NJOROGE, G., MWENDA, C., MECHA, E., WAITHAKA, S.
10.1101/2022.10.18.22281212 — Posted: 2022-10-20
MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN COURSE AMID COVID-19 PANDEMIC IN THE REBUBLIC OF BELARUS
Romanova, O., Kolomiets, N., Savitski, D., Dashkevich, A. M., Krasko, O., Batyan, G., Kluchareva, A., Sokolova, M., Sergienko, E., Hanenko, O., Matush, L., Senkevich, U.
10.1101/2022.10.14.22280869 — Posted: 2022-10-20
Alternative splicing in the lung influences COVID-19 severity and respiratory diseases.
Nakanishi, T., Yossi Farjoun, Y., Willett, J. D. S., Allen, R. J., Guillen-Guio, B., Zhou, S., Richards, J. B.
10.1101/2022.10.18.22281202 — Posted: 2022-10-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).